MedPath

Clinical Trial for Prostate Cancer

Phase 3
Completed
Conditions
Prostate Cancer
Registration Number
NCT00076531
Lead Sponsor
Oakwood Laboratories, LLC
Brief Summary

Phase III trial using an injectable for treatment of prostate cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath